%0 Journal Article
%T Nail lichen planus treatment safety.
%A Axler EN
%A Lipner SR
%J Expert Opin Drug Saf
%V 22
%N 12
%D 2023 Jul-Dec 28
%M 38014463
%F 4.011
%R 10.1080/14740338.2023.2288902
%X <B>UNASSIGNED: </B>Topical therapies for nail lichen planus (clobetasol propionate, topical tacrolimus, bath-PUVA), intralesional treatment (triamcinolone), and systemic treatment (corticosteroids, retinoids, small molecule inhibitors (jak/stat inhibitors)), TNF-alpha inhibitors (etanercept), systemic immunomodulators (oral calcineurin inhibitors, mycophenolate mophetil), and antimalarials (chloroquine), each with unique safety profiles and considerations. Herein, we discuss common and uncommon adverse events, as well as utilization for special populations, including pregnant and pediatric patients.